Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningitis | 2 | 2019 | 18 | 1.130 |
Why?
|
| Guillain-Barre Syndrome | 4 | 2024 | 10 | 0.850 |
Why?
|
| Encephalomyelitis | 1 | 2019 | 5 | 0.690 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2019 | 11 | 0.680 |
Why?
|
| Spinal Cord | 1 | 2019 | 195 | 0.630 |
Why?
|
| Fluconazole | 1 | 2013 | 14 | 0.450 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 11 | 0.450 |
Why?
|
| Neural Conduction | 3 | 2024 | 28 | 0.450 |
Why?
|
| Brain | 2 | 2019 | 1475 | 0.440 |
Why?
|
| Antifungal Agents | 1 | 2013 | 116 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 2013 | 0.290 |
Why?
|
| Tranylcypromine | 1 | 2007 | 2 | 0.290 |
Why?
|
| Electrodiagnosis | 2 | 2024 | 13 | 0.290 |
Why?
|
| Chorea | 1 | 2007 | 10 | 0.290 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 63 | 0.270 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 2 | 2003 | 2 | 0.270 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 48 | 0.270 |
Why?
|
| Lamin Type A | 2 | 2003 | 11 | 0.270 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 227 | 0.250 |
Why?
|
| Myoclonus | 1 | 2004 | 1 | 0.240 |
Why?
|
| Spinal Osteophytosis | 1 | 2004 | 3 | 0.240 |
Why?
|
| Skiing | 1 | 2004 | 11 | 0.240 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2004 | 17 | 0.240 |
Why?
|
| Spinal Cord Compression | 1 | 2004 | 28 | 0.240 |
Why?
|
| Depressive Disorder | 1 | 2007 | 292 | 0.230 |
Why?
|
| Methylprednisolone | 2 | 2021 | 29 | 0.220 |
Why?
|
| Cervical Vertebrae | 1 | 2004 | 99 | 0.220 |
Why?
|
| Penetrance | 1 | 2002 | 11 | 0.210 |
Why?
|
| Papilledema | 1 | 2021 | 9 | 0.200 |
Why?
|
| Optic Nerve Diseases | 1 | 2021 | 19 | 0.200 |
Why?
|
| Ulnar Neuropathies | 1 | 2021 | 1 | 0.200 |
Why?
|
| Cubital Tunnel Syndrome | 1 | 2021 | 2 | 0.200 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 6 | 0.190 |
Why?
|
| Elbow Joint | 1 | 2021 | 12 | 0.190 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 90 | 0.180 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 34 | 0.170 |
Why?
|
| Muscle Weakness | 2 | 2018 | 29 | 0.170 |
Why?
|
| Liver Transplantation | 1 | 2021 | 185 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2019 | 174 | 0.160 |
Why?
|
| Arthrogryposis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2018 | 1 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2019 | 167 | 0.150 |
Why?
|
| Mutation | 2 | 2003 | 2419 | 0.150 |
Why?
|
| Humans | 16 | 2024 | 58855 | 0.140 |
Why?
|
| Female | 9 | 2024 | 30564 | 0.140 |
Why?
|
| Adult | 8 | 2024 | 15602 | 0.130 |
Why?
|
| Lyme Disease | 1 | 2015 | 104 | 0.110 |
Why?
|
| Aged | 4 | 2024 | 13215 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2024 | 2428 | 0.100 |
Why?
|
| Recurrence | 1 | 2013 | 575 | 0.100 |
Why?
|
| Middle Aged | 6 | 2024 | 16127 | 0.100 |
Why?
|
| Male | 9 | 2024 | 27275 | 0.090 |
Why?
|
| Prognosis | 2 | 2023 | 1561 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2007 | 115 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 1446 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 1135 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 432 | 0.060 |
Why?
|
| Acute Disease | 1 | 2007 | 650 | 0.060 |
Why?
|
| Reflex, Babinski | 1 | 2004 | 1 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2004 | 16 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2004 | 27 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 27 | 0.060 |
Why?
|
| Ankle | 1 | 2004 | 19 | 0.060 |
Why?
|
| Thalidomide | 1 | 2004 | 33 | 0.060 |
Why?
|
| Decompression, Surgical | 1 | 2004 | 61 | 0.060 |
Why?
|
| Adolescent | 4 | 2018 | 5867 | 0.060 |
Why?
|
| Miller Fisher Syndrome | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2023 | 20 | 0.050 |
Why?
|
| Internationality | 1 | 2023 | 42 | 0.050 |
Why?
|
| Cell Count | 1 | 2023 | 128 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2002 | 42 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2002 | 55 | 0.050 |
Why?
|
| Pedigree | 1 | 2002 | 190 | 0.050 |
Why?
|
| Heterozygote | 1 | 2002 | 168 | 0.050 |
Why?
|
| Disease Progression | 2 | 2023 | 1030 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 195 | 0.050 |
Why?
|
| Exons | 1 | 2002 | 192 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2021 | 27 | 0.050 |
Why?
|
| Ulnar Nerve | 1 | 2021 | 6 | 0.050 |
Why?
|
| Elbow | 1 | 2021 | 8 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2003 | 203 | 0.050 |
Why?
|
| Reference Values | 1 | 2022 | 322 | 0.050 |
Why?
|
| Living Donors | 1 | 2021 | 62 | 0.050 |
Why?
|
| Genotype | 1 | 2002 | 641 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 181 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 333 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2021 | 447 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2024 | 474 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 670 | 0.040 |
Why?
|
| Child | 3 | 2021 | 4239 | 0.040 |
Why?
|
| Arm | 1 | 2018 | 38 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 893 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3074 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 180 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5099 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2015 | 403 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 5922 | 0.020 |
Why?
|
| Ependymoma | 1 | 2004 | 5 | 0.020 |
Why?
|
| Ulcer | 1 | 2004 | 12 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2004 | 19 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2004 | 50 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2004 | 39 | 0.010 |
Why?
|
| Electromyography | 1 | 2004 | 87 | 0.010 |
Why?
|
| Action Potentials | 1 | 2004 | 103 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 39 | 0.010 |
Why?
|
| Syncope | 1 | 2003 | 41 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 173 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2004 | 105 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2003 | 41 | 0.010 |
Why?
|
| Dyspnea | 1 | 2003 | 107 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2003 | 142 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 239 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 305 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 521 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 455 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 668 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2003 | 354 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 2316 | 0.010 |
Why?
|